Trans Pharmaceuticals Private Limited

Trans Pharmaceuticals Private Limited - pharma in Ahmednagar, Maharashtra, India. FY 2026 financials & compliance.
CIN U24112PN2010PTC136897 Incorporated 20 July 2010 ROC Pune HQ Ahmednagar, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2021
₹8.48 Lakh
▼ 85% YoY
Net loss · FY 2021
₹12.55 Lakh
Net margin -148.1%
EBITDA · FY 2021
-₹5.34 Lakh
EBITDA margin -63%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
8
Provident fund records

About Trans Pharmaceuticals Private Limited

Data last updated:

Trans Pharmaceuticals Private Limited is a private limited company based in Ahmednagar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24112PN2010PTC136897. Its GSTIN is 27AADCT5699J1ZM (Maharashtra).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Sanjay Harakchand Gugle and Ganesh Vishwasrao Chintawar.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 3391 Sukhada Apartment Manik Chouk, Ahmednagar, Maharashtra, India – 414001.

As per the financials filed for FY 2021, the company reported a revenue of ₹8.48 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹12.55 Lakh (net margin -148.1%) and EBITDA of -₹5.34 Lakh (EBITDA margin -63%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 48% over five years.

The company has about 8 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹60 Lakh on record. Court records list 5 cases involving the company, including 5 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24112PN2010PTC136897
Registration Number 136897
Incorporation Date 20 July 2010
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant

Contact details

Trans Pharmaceuticals Private Limited's registered office is in Ahmednagar, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    3391 Sukhada Apartment Manik Chouk, Ahmednagar, Maharashtra, India – 414001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Trans Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Trans Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Trans Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Trans Pharmaceuticals Private Limited, buy the company report.

Financials of Trans Pharmaceuticals Private Limited

FY 2021 filings available

Trans Pharmaceuticals Private Limited reported revenue of ₹8.48 Lakh (down 85% YoY) for FY 2021.

Revenue · FY 2021
₹8.48 Lakh ▼ 85%
Net loss · FY 2021
₹12.55 Lakh margin -148.1%
EBITDA · FY 2021
-₹5.34 Lakh margin -63%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 85%
3 years · compounded
▼ 59%
5 years · compounded
▼ 48%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 41%
5 years · compounded
▼ 20%

Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 85% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹8.48 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.34 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹12.55 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-63%
Net Profit Margin-148.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Trans Pharmaceuticals Private Limited, buy the company report.

Board of directors of Trans Pharmaceuticals Private Limited

Trans Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay Harakchand GugleDirector20 Jul 201016 Years 3 MonthsCurrent
Ganesh Vishwasrao ChintawarDirector21 Sep 201511 Years 1 MonthsCurrent
Satish Shankarrao GadewarDirector21 Sep 201511 Years 1 MonthsCurrent

Peer comparison

Trans Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zrox Pharmaceuticals Private Limited₹8.51 Lakh (FY 2021)-6.0%Yamuna Nagar, Haryana, India
Hyssop Pharmaceuticals Private Limited₹8.5 Lakh (FY 2024)-55.0%Ranchi, Jharkhand, India
Endospy Pharmaceuticals Private Limited₹8.48 Lakh (FY 2025)70.0%Pune, Maharashtra, India
Trans Pharmaceuticals Private Limitedthis company₹8.48 Lakh (FY 2021)-₹12.55 Lakh-148.1%-85.0%8Ahmednagar, Maharashtra, India
Wellborn Pharmaceuticals Private Limited₹8.44 Lakh (FY 2018)-43.0%New Delhi, Delhi, India
Kon Pharmaceuticals Trading Private Limited₹8.43 Lakh (FY 2025)13.0%Burdwan, West Bengal, India
Vagmin Pharmaceuticals Private Limited₹8.43 Lakh (FY 2019)Bangalore, Karnataka, India

To see the full peer comparison of Trans Pharmaceuticals Private Limited, buy the company report.

Auditor

Trans Pharmaceuticals Private Limited is audited by S P A Y & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
S P A Y & COFY 2021132976W

Shareholding

The shareholding of Trans Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Trans Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹60 Lakh
Satisfied charges
None
Breakdown by lending institutions
The Ahmednagar Merchant'S Co-Op.Bank Ltd.₹0.50 Cr
The Ahmednagar Merchants' Co-Operative Bank Limited₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Dec 201410572475The Ahmednagar Merchants' Co-Operative Bank Limited₹10 LakhOpen
11 Feb 201110305620The Ahmednagar Merchant'S Co-Op.Bank Ltd.₹50 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Trans Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Trans Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
8
Active EPFO establishments
1
Employee growth
-33.33%

GST

Trans Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AADCT5699J1ZMMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Trans Pharmaceuticals Private Limited, buy the company report.

Recent activity

Trans Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Jeevan Narayan Jadhav ceased to be Director on 16 May 2019.

AGM
Trans Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Trans Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Pune.
Ceased
Jeevan Narayan Jadhav ceased to be Director.
Appointed
Ganesh Vishwasrao Chintawar was appointed as Director.
Appointed
Satish Shankarrao Gadewar was appointed as Director.
Charges
A charge with The Ahmednagar Merchants' Co-Operative Bank Limited amounted to Rs. 10.00 Lakh with Charge ID 10572475 was registered on 12 Dec 2014.
Charges
A charge with The Ahmednagar Merchant'S Co-Op.Bank Ltd. amounted to Rs. 50.00 Lakh with Charge ID 10305620 was registered on 11 Feb 2011.
Appointed
Sanjay Harakchand Gugle was appointed as Director.
Incorporation
20 Jul 2010
Trans Pharmaceuticals Private Limited was registered on 20 Jul 2010 with Roc Pune & aged 16 years 3 months as per MCA records.

Frequently asked questions

Trans Pharmaceuticals is an active private limited company based in Ahmednagar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2010 (16+ years old) and is registered under CIN U24112PN2010PTC136897.

Trans Pharmaceuticals has 3 current directors:

The latest financial statements of Trans Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Trans Pharmaceuticals is 27AADCT5699J1ZM, registered in Maharashtra.

The CIN (Corporate Identification Number) of Trans Pharmaceuticals is U24112PN2010PTC136897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Trans Pharmaceuticals has 5 court cases on record: 5 filed against it.

Trans Pharmaceuticals was incorporated on 20 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Trans Pharmaceuticals by revenue are Zrox Pharmaceuticals Private Limited, Hyssop Pharmaceuticals Private Limited, Endospy Pharmaceuticals Private Limited, Wellborn Pharmaceuticals Private Limited, Kon Pharmaceuticals Trading Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Jeevan Narayan Jadhav ceased to be Director on 16 May 2019. Ganesh Vishwasrao Chintawar was appointed as Director on 21 Sep 2015. Satish Shankarrao Gadewar was appointed as Director on 21 Sep 2015. Trans Pharmaceuticals has 4 board changes on record in total.

The registered office of Trans Pharmaceuticals is at 3391 Sukhada Apartment Manik Chouk, Ahmednagar, Maharashtra, India – 414001.

Trans Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.